Published in Gut on February 01, 1983
British Thoracic Society guidelines on diagnostic flexible bronchoscopy. Thorax (2001) 3.95
Disinfection methods in general practice and health authority clinics: a telephone survey. J R Coll Gen Pract (1988) 2.41
Transmission of infection by flexible gastrointestinal endoscopy and bronchoscopy. Clin Microbiol Rev (2013) 2.01
Infection control revisited: dilemma facing today's bronchoscopists. BMJ (1988) 1.46
Patient to patient transmission of hepatitis B virus: a systematic review of reports on outbreaks between 1992 and 2007. BMC Med (2009) 1.19
Gastrointestinal endoscopy: infection and disinfection. Gut (1983) 1.09
Risk of transmission of carbapenem-resistant Enterobacteriaceae and related "superbugs" during gastrointestinal endoscopy. World J Gastrointest Endosc (2014) 1.04
Current issues in endoscope reprocessing and infection control during gastrointestinal endoscopy. World J Gastroenterol (2006) 1.01
Comparison on the Efficacy of Disinfectants Used in Automated Endoscope Reprocessors: PHMB-DBAC versus Orthophthalaldehyde. Clin Endosc (2011) 0.95
Recovery of the human immunodeficiency virus from fibreoptic bronchoscopes. Thorax (1991) 0.93
The flexible sigmoidoscope as a potential vector of infectious disease, including suggestions for decontamination of the flexible sigmoidoscope. Yale J Biol Med (1987) 0.92
The Occurrence and Prevention of Infections Associated with Gastrointestinal Endoscopy. Curr Infect Dis Rep (2003) 0.82
Exposure to hepatitis B: review of current concepts. Bull N Y Acad Med (1989) 0.75
Cross-contamination and cross-infection risk of otoscope heads. Eur Arch Otorhinolaryngol (2013) 0.75
Disinfection of gastrointestinal fibre endoscopes. Lancet (1974) 1.71
Viral hepatitis B: aspects of environmental control. Health Lab Sci (1977) 1.64
Letter: Endoscopy and transmission of hepatitis B. Lancet (1975) 1.35
Can gastrointestinal endoscopy transmit hepatitis B to patients? Gastrointest Endosc (1976) 1.01
Hepatitis B: absence of transmission by gastrointestinal endoscopy. Br Med J (1978) 1.00
An epidemiological and clinical evaluation of hepatitis b surface antigen subtypes in acute hepatitis in West of Scotland. Health Bull (Edinb) (1977) 0.92
Lack of transmission of type B hepatitis by fiberoptic upper endoscopy. J Clin Gastroenterol (1980) 0.91
Failure of endoscopic transmission of hepatitis B. Dig Dis Sci (1979) 0.90
Local complications of ulcerative colitis: stricture, pseudopolyposis, and carcinoma of colon and rectum. Br Med J (1966) 4.27
Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut (2010) 3.67
Enteroviral RNA sequences detected by polymerase chain reaction in muscle of patients with postviral fatigue syndrome. BMJ (1991) 3.65
Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol (2000) 3.08
Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology. Neurology (1992) 2.57
Trial of a supplemental dose of four poliovirus vaccines. N Engl J Med (2000) 2.35
Early course of ulcerative colitis. Gut (1966) 2.26
Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Antonie Van Leeuwenhoek (1999) 2.14
Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology (1996) 2.14
HTLV-III antibody in drug abusers in the west of Scotland: the Edinburgh connection. Lancet (1986) 1.88
Sequences specific for enterovirus detected in spinal cord from patients with motor neurone disease. BMJ (1994) 1.83
Hepatocellular carcinoma in primary biliary cirrhosis: report of four cases. Gut (1979) 1.83
Long-term prognosis of ulcerative colitis. Br Med J (1966) 1.77
Primary biliary cirrhosis: an increased incidence of extrahepatic malignancies? J Clin Pathol (1982) 1.69
Extracorporeal shock wave lithotripsy: the first 50 patients treated in Britain. Br Med J (Clin Res Ed) (1985) 1.66
Hepatitis Bs antibody in alcoholic cirrhosis. J Clin Pathol (1979) 1.61
Incidence of sulphasalazine-induced male infertility. Gut (1981) 1.58
Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation. Lancet (1995) 1.57
Diagnosis of inflammatory bowel disease: an international multicentre scoring system. Br Med J (Clin Res Ed) (1982) 1.53
The early course and prognosis of ulcerative colitis. Proc R Soc Med (1965) 1.52
Measurement of gastrointestinal motility in the GI laboratory. Gastroenterology (1998) 1.52
Idiopathic chronic ulcerative enteritis. Report of five cases and review of the literature. Q J Med (1980) 1.48
Gastroparesis as a cause of nausea and vomiting after high-dose chemotherapy and haemopoietic stem-cell transplantation. Lancet (1999) 1.48
Intraperitoneal perforation of the colon in ulcerative colitis. Proc R Soc Med (1965) 1.48
Histocompatibility antigens in active chronic hepatitis and primary biliary cirrhosis. Br Med J (1974) 1.45
Gastrointestinal symptoms in Parkinson's disease. Mov Disord (1991) 1.44
Motility of the terminal ileum and ileocecal sphincter in healthy humans. Gastroenterology (1984) 1.42
Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA. Int J Cancer (1975) 1.41
Inflammatory polyps as a manifestation of intestinal graft versus host disease. Gastrointest Endosc (1993) 1.40
pH of the microclimate lining human gastric and duodenal mucosa in vivo. Studies in control subjects and in duodenal ulcer patients. Gastroenterology (1987) 1.39
An examination of the reliability of reported stool frequency in the diagnosis of idiopathic constipation. Am J Gastroenterol (1996) 1.34
The herpes simplex virus type 2 (HG52) variant JH2604 has a 1488 bp deletion which eliminates neurovirulence in mice. J Gen Virol (1989) 1.33
Early surgery in the management of severe ulcerative colitis. Br Med J (1967) 1.27
Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease. Int J Cancer (1999) 1.26
The O.M.G.E. Multinational Inflammatory Bowel Disease Survey 1976-1982. A further report on 2,657 cases. Scand J Gastroenterol Suppl (1984) 1.26
Further evidence for an association between psoriasis, Crohn's disease and ulcerative colitis. Br J Dermatol (1982) 1.25
Computer interrogation of patients. Br Med J (1976) 1.25
Ulcerative colitis and pregnancy. Lancet (1965) 1.24
Review article: probiotics for the treatment of irritable bowel syndrome--focus on lactic acid bacteria. Aliment Pharmacol Ther (2012) 1.24
Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group. Digestion (2009) 1.19
Differential susceptibility of human neural cell types in culture to infection with herpes simplex virus. Brain (1983) 1.18
Surgical approach to short-bowel syndrome. Experience in a population of 160 patients. Ann Surg (1995) 1.17
Latin-American Consensus Conference on Helicobacter pylori infection. Latin-American National Gastroenterological Societies affiliated with the Inter-American Association of Gastroenterology (AIGE). Am J Gastroenterol (2000) 1.17
Surveillance of Mycoplasma pneumoniae infections in Scotland 1986-1991. J Infect (1992) 1.13
Incidence and management of anorectal abscess, fistula and fissure, in patients with ulcerative colitis. Dis Colon Rectum (1966) 1.12
Ocular complications of ulcerative colitis. Gut (1967) 1.12
Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis. Diabetes Care (1998) 1.12
Studies in the rates of epithelial cell exfoliation from the gastric mucosa in normal and in ulcer subjects. Gut (1971) 1.12
Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group. Clin Ther (1998) 1.11
Superior mesenteric artery thrombosis after colonoscopy. Gastrointest Endosc (1999) 1.11
Reactivation of latent herpes simplex virus from dissociated identified dorsal root ganglion cells in culture. J Gen Virol (1983) 1.11
Altered peripheral toll-like receptor responses in the irritable bowel syndrome. Aliment Pharmacol Ther (2011) 1.10
Controlled trial of heater probe treatment in bleeding peptic ulcers. Br J Surg (1989) 1.09
Antibodies to cytomegalovirus in renal allograft recipients: correlation with isolation of virus. J Clin Pathol (1989) 1.08
Symptoms and gastric function in dyspepsia--goodbye to gastroparesis? Neurogastroenterol Motil (1996) 1.08
Motility of the ileocolonic junction. Gut (1988) 1.06
Azathioprine in primary biliary cirrhosis: a preliminary report of an international trial. Gastroenterology (1980) 1.06
The management of ulcerative colitis. Practitioner (1976) 1.05
Colorectal cancer screening compliance by medicine residents: perceived and actual. Am J Gastroenterol (2001) 1.05
Drug metabolism in liver disease. Pharmacol Ther (1989) 1.05
Characterization of swallowing and defecation in Parkinson's disease. Am J Gastroenterol (1994) 1.05
Enterovirus variants in the serum of children at the onset of Type 1 diabetes mellitus. Diabet Med (1999) 1.04
Intestinal motility in irritable bowel syndrome: is IBS a motility disorder? Part 1. Definition of IBS and colonic motility. Dig Dis Sci (1993) 1.04
Evidence for previous hepatitis B virus infection in alcoholic cirrhosis. Br Med J (Clin Res Ed) (1981) 1.04
Pharmacological management of constipation. Neurogastroenterol Motil (2009) 1.04
Peptic ulcer and cancer: an examination of the relationship between chronic peptic ulcer and gastric carcinoma. Scand J Gastroenterol (1987) 1.03
Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterol Motil (2014) 1.03
Jaundice associated with the use of benoxaprofen. Lancet (1982) 1.03
Chylous ascites, intestinal lymphangiectasia and the 'yellow-nail' syndrome. Gut (1985) 1.02
A variant of herpes simplex virus type 2 strain HG52 with a 1.5 kb deletion in RL between 0 to 0.02 and 0.81 to 0.83 map units is non-neurovirulent for mice. J Gen Virol (1989) 1.02
A study of enterovirus isolations in Glasgow from 1977 to 1997. J Med Virol (1999) 1.02
The ileocecal (ileocolonic) sphincter. Z Gastroenterol (1983) 1.01
Hepatic granulomas: experience over a 10-year period in the West of Scotland. Q J Med (1982) 1.01
Sulphasalazine: a review of 40 years' experience. Drugs (1986) 1.01
Effects of morphine and atropine on motility and transit in the human ileum. Gastroenterology (1985) 1.01
Radiological appearances of ulcerative colitis: an evaluation of their clinical significance. Gut (1968) 1.00
Familial occurrence of primary sclerosing cholangitis and ulcerative colitis. Gastroenterology (1983) 1.00
Pharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcoholic cirrhosis. Gut (1986) 0.99
Phytohaemagglutinin (PHA) induced lymphocyte transformation and Toxoplasma gondii antibody studies in primary biliary cirrhosis. Evidence of impaired cell-mediated immunity. Clin Exp Immunol (1973) 0.99
Principles of applied neurogastroenterology: physiology/motility-sensation. Gut (1999) 0.99
Distinctive patterns of interdigestive motility at the canine ileocolonic junction. Gastroenterology (1984) 0.98
Delayed gastric emptying of both the liquid and solid components of a meal in chronic liver disease. Am J Gastroenterol (1994) 0.98
Constipation in Parkinson's disease: objective assessment and response to psyllium. Mov Disord (1997) 0.97
Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation. Aliment Pharmacol Ther (1995) 0.97
Gastrointestinal dysfunction in liver disease and portal hypertension. Gut-liver interactions revisited. Dig Dis Sci (1996) 0.96
Gastrointestinal dysfunction in Parkinson's disease. A report of clinical experience at a single center. J Clin Gastroenterol (1994) 0.95
Aetiology of ulcerative colitis. II. A new hypothesis. Gut (1969) 0.95
Alcoholic liver disease in Scotland and northeastern England: presenting features in 510 patients. Q J Med (1983) 0.94
Simple technique for detecting RNA viruses by PCR in single sections of wax embedded tissue. J Clin Pathol (1993) 0.94
A clinical trial of the efficacy and acceptability of D-fenfluramine in the treatment of neuroleptic-induced obesity. Br J Psychiatry (1988) 0.94
Efficacy of prolonged administration of intravenous erythromycin in an ambulatory setting as treatment of severe gastroparesis: one center's experience. J Clin Gastroenterol (1999) 0.93
An epidemiological and clinical evaluation of hepatitis b surface antigen subtypes in acute hepatitis in West of Scotland. Health Bull (Edinb) (1977) 0.92